Authors: Sommer, K Peters, SO Robins, IH Raap, M Wiedemann, GJ Remmert, S Sieg, P Bittner, C Feyerabend, T

Citation: K. Sommer et al., A preclinical model for experimental chemotherapy of human head and neck cancer, INT J ONCOL, 18(6), 2001, pp. 1145-1149

Authors: Hanel, M Kroger, N Hoffknecht, MM Peters, SO Metzner, B Fiedler, F Braumann, D Schubert, JC Illiger, HJ Hanel, A Kruger, WH Zeller, W Weh, HJ Hossfeld, DK Zander, AR

Citation: M. Hanel et al., ASHAP - an effective salvage therapy for recurrent and refractory malignant lymphomas, ANN HEMATOL, 79(6), 2000, pp. 304-311

Authors: Horvath, V Hartlapp, JH Hegewisch-Becker, S Feyerabend, T von Weikersthal, LF Illiger, HJ Jager, E Peters, SO Reichardt, P Uthgenannt, D Weber, K Wagner, T Wiedemann, GJ Zschaber, R

Citation: V. Horvath et al., Oral trofosfamide in elderly and/or heavily pretreated patients with metastatic lung cancer, ONKOLOGIE, 23(4), 2000, pp. 341-344

Authors: Borner, K Kisro, J Bruggemann, SK Hagenah, W Peters, SO Wagner, T

Citation: K. Borner et al., Metabolism of ifosfamide to chloroacetaldehyde contributes to antitumor activity in vivo, DRUG META D, 28(5), 2000, pp. 573-576

Authors: Peters, SO Habibian, HK Vergilis, K Quesenberry, PJ

Citation: So. Peters et al., Effects of cytokines on stem cell engraftment depends on rime of evaluation post-marrow-infusion, INT J HEMAT, 70(2), 1999, pp. 112-118